Kyverna Therapeutics, Inc.
KYTX • NASDAQ
Kyverna Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Warner Biddle, with a market cap of $471.6M.
CEOWarner Biddle
Next Earnings
Upcoming earnings announcement for Kyverna Therapeutics, Inc.
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.78
Earnings History
Past 8 earnings reports for Kyverna Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Q4 2025 | -$0.80Est: -$0.84 | +4.8% | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.85Est: -$0.96 | +11.5% | - | — | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.97Est: -$1.03 | +5.8% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$1.03Est: -$0.99 | -4.0% | - | — | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.74Est: -$0.79 | +6.3% | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.80Est: -$0.80 | 0.0% | - | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.67Est: -$0.64 | -4.7% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$1.12Est: -$0.84 | -33.3% | - | — | 10-Q |